U.S. markets closed
  • S&P Futures

    3,439.50
    +16.75 (+0.49%)
     
  • Dow Futures

    28,217.00
    +117.00 (+0.42%)
     
  • Nasdaq Futures

    11,724.50
    +74.25 (+0.64%)
     
  • Russell 2000 Futures

    1,619.90
    +8.60 (+0.53%)
     
  • Crude Oil

    40.61
    -0.22 (-0.54%)
     
  • Gold

    1,903.90
    -7.80 (-0.41%)
     
  • Silver

    24.58
    -0.12 (-0.48%)
     
  • EUR/USD

    1.1780
    +0.0007 (+0.06%)
     
  • 10-Yr Bond

    0.7610
    +0.0170 (+2.28%)
     
  • Vix

    29.18
    +1.77 (+6.46%)
     
  • GBP/USD

    1.2950
    +0.0010 (+0.07%)
     
  • USD/JPY

    105.5510
    +0.1210 (+0.11%)
     
  • BTC-USD

    11,746.59
    +689.58 (+6.24%)
     
  • CMC Crypto 200

    239.24
    +5.57 (+2.39%)
     
  • FTSE 100

    5,884.65
    -34.93 (-0.59%)
     
  • Nikkei 225

    23,577.79
    -93.34 (-0.39%)
     

An Intrinsic Calculation For Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Suggests It's 43% Undervalued

Simply Wall St
·6 mins read

How far off is Acadia Healthcare Company, Inc. (NASDAQ:ACHC) from its intrinsic value? Using the most recent financial data, we'll take a look at whether the stock is fairly priced by projecting its future cash flows and then discounting them to today's value. One way to achieve this is by employing the Discounted Cash Flow (DCF) model. It may sound complicated, but actually it is quite simple!

We would caution that there are many ways of valuing a company and, like the DCF, each technique has advantages and disadvantages in certain scenarios. Anyone interested in learning a bit more about intrinsic value should have a read of the Simply Wall St analysis model.

See our latest analysis for Acadia Healthcare Company

Is Acadia Healthcare Company fairly valued?

We're using the 2-stage growth model, which simply means we take in account two stages of company's growth. In the initial period the company may have a higher growth rate and the second stage is usually assumed to have a stable growth rate. To begin with, we have to get estimates of the next ten years of cash flows. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.

A DCF is all about the idea that a dollar in the future is less valuable than a dollar today, so we need to discount the sum of these future cash flows to arrive at a present value estimate:

10-year free cash flow (FCF) forecast

2021

2022

2023

2024

2025

2026

2027

2028

2029

2030

Levered FCF ($, Millions)

US$183.7m

US$301.0m

US$326.7m

US$348.3m

US$366.8m

US$382.9m

US$397.2m

US$410.2m

US$422.3m

US$433.9m

Growth Rate Estimate Source

Analyst x4

Analyst x1

Est @ 8.52%

Est @ 6.63%

Est @ 5.31%

Est @ 4.38%

Est @ 3.73%

Est @ 3.28%

Est @ 2.96%

Est @ 2.74%

Present Value ($, Millions) Discounted @ 9.5%

US$168

US$251

US$249

US$243

US$233

US$223

US$211

US$199

US$187

US$176

("Est" = FCF growth rate estimated by Simply Wall St)
Present Value of 10-year Cash Flow (PVCF) = US$2.1b

The second stage is also known as Terminal Value, this is the business's cash flow after the first stage. The Gordon Growth formula is used to calculate Terminal Value at a future annual growth rate equal to the 5-year average of the 10-year government bond yield of 2.2%. We discount the terminal cash flows to today's value at a cost of equity of 9.5%.

Terminal Value (TV)= FCF2030 × (1 + g) ÷ (r – g) = US$434m× (1 + 2.2%) ÷ (9.5%– 2.2%) = US$6.1b

Present Value of Terminal Value (PVTV)= TV / (1 + r)10= US$6.1b÷ ( 1 + 9.5%)10= US$2.5b

The total value is the sum of cash flows for the next ten years plus the discounted terminal value, which results in the Total Equity Value, which in this case is US$4.6b. The last step is to then divide the equity value by the number of shares outstanding. Compared to the current share price of US$29.4, the company appears quite undervalued at a 43% discount to where the stock price trades currently. The assumptions in any calculation have a big impact on the valuation, so it is better to view this as a rough estimate, not precise down to the last cent.

dcf
dcf

The assumptions

The calculation above is very dependent on two assumptions. The first is the discount rate and the other is the cash flows. Part of investing is coming up with your own evaluation of a company's future performance, so try the calculation yourself and check your own assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Acadia Healthcare Company as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 9.5%, which is based on a levered beta of 1.204. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.

Next Steps:

Valuation is only one side of the coin in terms of building your investment thesis, and it shouldn't be the only metric you look at when researching a company. The DCF model is not a perfect stock valuation tool. Preferably you'd apply different cases and assumptions and see how they would impact the company's valuation. For instance, if the terminal value growth rate is adjusted slightly, it can dramatically alter the overall result. What is the reason for the share price sitting below the intrinsic value? For Acadia Healthcare Company, we've compiled three essential aspects you should explore:

  1. Risks: You should be aware of the 2 warning signs for Acadia Healthcare Company (1 is concerning!) we've uncovered before considering an investment in the company.

  2. Future Earnings: How does ACHC's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.

  3. Other High Quality Alternatives: Do you like a good all-rounder? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing!

PS. Simply Wall St updates its DCF calculation for every American stock every day, so if you want to find the intrinsic value of any other stock just search here.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.